Obesity risk depends on muscle and fat, not weight alone Doctors often rely on body mass index (BMI) to gauge health risks related to weight. BMI is quick, but it cannot tell fat from muscle […]
Understanding a challenging lymphoma Gastrointestinal diffuse large B-cell lymphoma (GI-DLBCL) is one of the most frequent types of extranodal non-Hodgkin lymphoma, accounting for 30–40 percent of all such cases. It usually begins in the stomach […]
Meta-analysis highlights long-term advantages in type 2 diabetes treatment Type 2 diabetes mellitus (T2DM) is a chronic disease marked by insulin resistance and progressive β-cell decline. As the condition advances, many patients experience rising blood […]
Understanding Periodontitis: More Than Just Bacteria Periodontitis is a long-lasting inflammatory disease that damages the tissues holding teeth in place and can lead to tooth loss. It begins with a harmful biofilm of bacteria, but […]
Pulmonary fibrosis (PF) is the end stage of several interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis. Progressive scarring destroys lung architecture, impairs gas exchange, and leads to respiratory failure. Outcomes […]
Tuberculosis Tuberculosis (TB) remains a major global health problem. In 2022, an estimated 10.6 million people developed TB and 1.3 million died from the disease. Despite available treatments, TB control is hindered by transmission, drug […]
Glioblastoma Progression and the Peritumor Niche Glioblastoma (GBM) is a malignant brain tumor characterized by rapid growth, invasive infiltration, and resistance to current treatments. Tumor recurrence frequently originates in the peritumor region, where glioblastoma cells […]
A Closer Look at Pediatric Acute Lymphoblastic Leukemia Acute lymphoblastic leukemia (ALL) is one of the most common blood cancers in children. Thanks to advances in therapy, survival rates now exceed 90%. Despite this progress, […]
Colorectal Cancer: A Global Challenge Colorectal cancer (CRC) is among the most common and deadly cancers worldwide. It accounts for 9.6% of all cancer cases and is the second leading cause of cancer-related death, responsible […]
Background and rationale Lung cancer remains the leading cause of cancer-related mortality worldwide; non-small cell lung cancer (NSCLC) accounts for about 85% of cases. Despite advances, prognosis is poor, especially at advanced stages. Immune checkpoint […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH